April 6, 2017 7:17pm

 

Investors are continually confused or distracted by short-term moves

 

It is also another example of how the sector can do the opposite of what many expect if any outlook is alleged  - “buy the rumor, sell any news” …

 

Pre-open indications:  5 hits and 1 miss                                                                   

 

I answer one question, in which company should investors commit and keep their money

 


 

RMi’s daily and continual “reads” of the goings-on of the SCG&RT sector can improve investor’s and trader’s odds - just because a stock underperforms the market doesn’t mean you have to lose money.

 

 

Henry’omics:

From the pre-open’s investor’s letter title,” I compiled the answer to recent questions about the cell therapy sector… and, the response was … who cares? The worst case, have we reached the point where if one can’t say anything good, why think anything at all?”

  • Reiterating, “After three (3) days of negative sector sessions, it’s time for an up day … IF there is recognition of the oversold. But, how do we make that judgement?”

The sector reacts like it's a bit twitchy and twerking.

  • “Our” universe has been trying to stymie losses and stimulate any gains, but it's thinking that a lot won’t work as we go ahead if the fluctuations continue.

There is a lack of real news that could affect any share pricing appreciation and sustainability.

 

Sentiment is extremely nowhere and totally dependent on trading … the oversold to an overbought and back yet again ...

 

 

What analytics were there today and why it was important in today’s sector outcomes?

The DOW closed up+15 or +0.07% to 20,663.15 while the NASDAQ closed +14.47 or +0.25% to 5878.95 …

… The CBOE Volatility Index (VIX) widely considered the best gauge of fear in the market, traded near 12.1 following Wednesday’s 11 following Tuesday’s 12 after Monday’s 12.3 after Friday’s 12.3 following last Thursday’s 11.6

…The iShares Russell 2000 (IWM) indicated a down -0.07% at the pre-open was and closed UP +0.93%;

… The iShares NASDAQ Biotechnology (IBB) did NOT indicate at the pre-open and closed UP +0.28%.

 

The advance/decline line scenario of 43 SCGT & RT covered companies:   

·         The opening bell was negative with an A/DL of 17/22 and 4 flats;

·         The mid-day stayed negative with an A/DL of 18/24 and 1 flat;

·         The close was positive with an A/DL of 25/16 and 2 flats;

 

Decliners ranged from -0.67% <CLLS> to -9.78% <BCLI> in 16 equities;

Gainers ranged from +0.48% <XON> to +6.45% <STML> in 25 equities;

 

Pre-open indications: 5 hits and 1 miss

  • Applied Genetic Technologies (AGTC) closed down -0.15 – hit;
  • Biostage (BSTG) closed down - $0.0047 – hit;
  • Brainstorm Cell Therapy (BCLI) closed down -$0.44 – hit;
  • Kite Pharma (KITE) closed up +$2.54 – miss;
  • Mesoblast (MESO) closed up +$0.16 – hit;
  •  VistaGen (VTGN) closed down - $0.05 – hit;

 

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.